SE9600648D0 - Receptorbimdande enhet - Google Patents
Receptorbimdande enhetInfo
- Publication number
- SE9600648D0 SE9600648D0 SE9600648A SE9600648A SE9600648D0 SE 9600648 D0 SE9600648 D0 SE 9600648D0 SE 9600648 A SE9600648 A SE 9600648A SE 9600648 A SE9600648 A SE 9600648A SE 9600648 D0 SE9600648 D0 SE 9600648D0
- Authority
- SE
- Sweden
- Prior art keywords
- pct
- receptor molecules
- receptor binding
- binding unit
- sec
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Nanotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9600648A SE9600648D0 (sv) | 1996-02-21 | 1996-02-21 | Receptorbimdande enhet |
| AT97905539T ATE258066T1 (de) | 1996-02-21 | 1997-02-20 | Ein hydrophobes rezeptormolekül für antigene stoffen enthaltender immunstimulierender komplex (iscom) oder matrix gebundener immunstimulierender komplex (iscom-matrix) |
| US09/125,588 US6027732A (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| EP97905539A EP0944397B1 (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| ES97905539T ES2214608T3 (es) | 1996-02-21 | 1997-02-20 | Moleculas hidrofobas receptoras de sustancias antigenas y que comprenden complejos inmunoestimulantes o matrices complejas inmunoestimulantes. |
| DE1997627314 DE69727314T2 (de) | 1996-02-21 | 1997-02-20 | Ein ISCOM oder eine ISCOM-Matrix, umfassend hydrophobe Rezeptormoleküle für antigene Stoffe |
| AU22383/97A AU718443B2 (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| BR9707638-4A BR9707638A (pt) | 1996-02-21 | 1997-02-20 | Particula contendo lipìdeos, escolhidas dentre iscoms e matriz de iscoms, e, preparacao de vacina para profilaxia e/ou imunoterapia. |
| PCT/SE1997/000287 WO1997030726A1 (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| CA002247103A CA2247103C (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
| DK97905539T DK0944397T3 (da) | 1996-02-21 | 1997-02-20 | Iscom eller iscom-matrix indeholdende hydrofobe receptormolekyler til antigene stoffer |
| NZ331418A NZ331418A (en) | 1996-02-21 | 1997-02-20 | Iscom or iscom-matrix comprising hydrophobic receptor molecules for antigenic substances |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9600648A SE9600648D0 (sv) | 1996-02-21 | 1996-02-21 | Receptorbimdande enhet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9600648D0 true SE9600648D0 (sv) | 1996-02-21 |
Family
ID=20401482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9600648A SE9600648D0 (sv) | 1996-02-21 | 1996-02-21 | Receptorbimdande enhet |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6027732A (xx) |
| EP (1) | EP0944397B1 (xx) |
| AT (1) | ATE258066T1 (xx) |
| AU (1) | AU718443B2 (xx) |
| BR (1) | BR9707638A (xx) |
| CA (1) | CA2247103C (xx) |
| DE (1) | DE69727314T2 (xx) |
| DK (1) | DK0944397T3 (xx) |
| ES (1) | ES2214608T3 (xx) |
| NZ (1) | NZ331418A (xx) |
| SE (1) | SE9600648D0 (xx) |
| WO (1) | WO1997030726A1 (xx) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US20030026782A1 (en) * | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
| US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US6693086B1 (en) * | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
| US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
| US7776343B1 (en) * | 1999-02-17 | 2010-08-17 | Csl Limited | Immunogenic complexes and methods relating thereto |
| JP2003514872A (ja) * | 1999-11-19 | 2003-04-22 | シーエスエル、リミテッド | ワクチン組成物 |
| SE0003538D0 (sv) * | 2000-09-29 | 2000-09-29 | Isconova Ab | New immunogenic complex |
| US7713942B2 (en) * | 2001-04-04 | 2010-05-11 | Nordic Vaccine Technology A/S | Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides |
| US20030138434A1 (en) * | 2001-08-13 | 2003-07-24 | Campbell Robert L. | Agents for enhancing the immune response |
| ATE361097T1 (de) * | 2002-01-15 | 2007-05-15 | Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh | Orale vakzinierung mit dem tumor-antigen-mimotop gln-met-trp-ala-pro-gln-trp-gly-pro-asp |
| US20040235770A1 (en) * | 2003-04-02 | 2004-11-25 | Coley Pharmaceutical Group, Ltd. | Immunostimulatory nucleic acid oil-in-water formulations and related methods of use |
| US20050013812A1 (en) * | 2003-07-14 | 2005-01-20 | Dow Steven W. | Vaccines using pattern recognition receptor-ligand:lipid complexes |
| TWI235440B (en) * | 2004-03-31 | 2005-07-01 | Advanced Semiconductor Eng | Method for making leadless semiconductor package |
| EP1781325A2 (en) * | 2004-07-18 | 2007-05-09 | CSL Limited | Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses |
| EP2468300B1 (en) | 2006-09-26 | 2017-12-20 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| US20090181078A1 (en) * | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| ES2325243B1 (es) * | 2008-02-27 | 2011-05-04 | Universidad De Granada | Antigeno recombinante. |
| CN102481312B (zh) | 2009-06-05 | 2015-07-15 | 传染性疾病研究院 | 合成的吡喃葡萄糖脂佐剂 |
| EA027236B1 (ru) | 2011-04-08 | 2017-07-31 | Иммьюн Дизайн Корп. | Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа |
| ES2729967T3 (es) | 2012-02-07 | 2019-11-07 | Infectious Disease Res Inst | Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas |
| EP3388835B1 (en) | 2012-05-16 | 2020-04-01 | Immune Design Corp. | Vaccines for hsv-2 |
| CN105209047B (zh) | 2013-04-18 | 2020-08-18 | 免疫设计股份有限公司 | 用于癌症治疗的gla单一疗法 |
| US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
| US11801223B2 (en) | 2013-12-31 | 2023-10-31 | Access To Advanced Health Institute | Single vial vaccine formulations |
| CA3141577A1 (en) | 2019-05-25 | 2020-12-03 | Infectious Disease Research Institute | Composition and method for spray drying an adjuvant vaccine emulsion |
| EP4058581A1 (en) | 2019-11-15 | 2022-09-21 | Infectious Disease Research Institute | Rig-i agonist and adjuvant formulation for tumor treatment |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2403081A1 (fr) * | 1977-09-19 | 1979-04-13 | Merieux Inst | Nouveau materiau particulaire, sa preparation et son application, notamment comme medicament |
| US5178860A (en) * | 1989-09-01 | 1993-01-12 | Coopers Animal Health Limited | Adjuvant complexes and vaccine made therefrom |
| NL9002314A (nl) * | 1990-10-23 | 1992-05-18 | Nederlanden Staat | Immunogene complexen, in het bijzonder iscoms. |
-
1996
- 1996-02-21 SE SE9600648A patent/SE9600648D0/xx unknown
-
1997
- 1997-02-20 CA CA002247103A patent/CA2247103C/en not_active Expired - Fee Related
- 1997-02-20 ES ES97905539T patent/ES2214608T3/es not_active Expired - Lifetime
- 1997-02-20 EP EP97905539A patent/EP0944397B1/en not_active Expired - Lifetime
- 1997-02-20 AU AU22383/97A patent/AU718443B2/en not_active Expired
- 1997-02-20 WO PCT/SE1997/000287 patent/WO1997030726A1/en active IP Right Grant
- 1997-02-20 US US09/125,588 patent/US6027732A/en not_active Expired - Lifetime
- 1997-02-20 BR BR9707638-4A patent/BR9707638A/pt not_active IP Right Cessation
- 1997-02-20 DE DE1997627314 patent/DE69727314T2/de not_active Expired - Lifetime
- 1997-02-20 NZ NZ331418A patent/NZ331418A/xx not_active IP Right Cessation
- 1997-02-20 DK DK97905539T patent/DK0944397T3/da active
- 1997-02-20 AT AT97905539T patent/ATE258066T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2247103C (en) | 2009-01-20 |
| BR9707638A (pt) | 2000-01-04 |
| US6027732A (en) | 2000-02-22 |
| DE69727314D1 (de) | 2004-02-26 |
| NZ331418A (en) | 2000-03-27 |
| WO1997030726A1 (en) | 1997-08-28 |
| AU2238397A (en) | 1997-09-10 |
| CA2247103A1 (en) | 1997-08-28 |
| DE69727314T2 (de) | 2004-11-18 |
| AU718443B2 (en) | 2000-04-13 |
| ATE258066T1 (de) | 2004-02-15 |
| DK0944397T3 (da) | 2004-06-01 |
| EP0944397A1 (en) | 1999-09-29 |
| EP0944397B1 (en) | 2004-01-21 |
| ES2214608T3 (es) | 2004-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9600648D0 (sv) | Receptorbimdande enhet | |
| PT1042001E (pt) | Uso de microparticulas combinadas com emulsoes submicronicas oleo-em-agua | |
| ATE360032T1 (de) | Cystein-reiche rezeptoren-train | |
| EP2298333A3 (en) | Tweak receptor | |
| EP1106183A3 (en) | Antibodies to erbB2 and their therapeutic uses | |
| AU1914795A (en) | Monoclonal antibodies specific to vegf receptors and uses thereof | |
| DE69942774D1 (de) | Verwendung von bioadhaesiven und adjuvantien für die mukosale anwendung von antigenen | |
| DE69925909D1 (de) | T-zell inhibierende rezeptorzusammensetzungen sowie deren verwendung | |
| ATE391203T1 (de) | Federfüllung, verfahren und vorrichtung | |
| EP1580271A3 (en) | Human Orphan G Protein-Coupled Receptors | |
| AP1424A (en) | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens. | |
| NO307877B1 (no) | Ikke eksplosive vann-i-olje-emulsjon- kunstgjødselsammensetninger | |
| ES2149625T3 (es) | Lamina para limpieza. | |
| TR200102041T2 (tr) | Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar | |
| DE69120942D1 (de) | Hilfsstoffzusammensetzungen in fester form, dispergieren in wässerigen medien | |
| YU41998A (sh) | Tetrahidrobetakarbolinska jedinjenja | |
| ATE245632T1 (de) | Benzodiazepin derivate verwendbar als cck- rezeptoren antagonisten | |
| WO2000003724A1 (fr) | Preparations pour immunotherapie anticancereuse comprenant un constituant somatique bacterien en tant qu'ingredient actif | |
| GR3026273T3 (en) | Infilling system for walls and linings of buildings | |
| ATE239035T1 (de) | Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendungen | |
| YU2792A (sh) | Disperzije finih čestica, antihelmintno efikasnih derivata, benzimidazola ili benztiazola ili pro-benzimidazola u vodi | |
| NO970341L (no) | Imidazopyridin-azolidinoner | |
| TR199800152T1 (xx) | Endotelin Resept�r Antagonistleri | |
| ES2169835T3 (es) | Mezcla de colagenos. | |
| ZA984838B (en) | Bacterial pheromones and uses therefor. |